5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)Primary Membranous NephropathyRecruitingPhase 2 / Phase 32026-09-18NCT07204275
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosusActive, not recruitingPhase 22026-07-20NCT05540327
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)Lipoprotein DisorderRecruitingPhase 22026-06-25NCT07327840
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARBFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorderRecruitingPhase 32026-02-03NCT05183646
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune DiseasesFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorderNot yet recruitingPhase 1 / Phase 22025-01-14NCT06774664